Related Experiment Video
Updated: Sep 14, 2025
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
9.7K
Value-based drug expenditures: a rational program for the United States
1Professor Emeritous, Rutgers Robert Wood Johnson Medical School New Brunswick, Westfield, Mass, United States.
The American Journal of Medicine
|July 22, 2025
Summary
High drug costs are a major medical care problem. A proposed 2028 reform includes a value-based heuristic model and a presidential committee for necessary changes.
Area of Science:
- Health Economics
- Healthcare Policy
- Medical Innovation
Background:
- Current medical care faces significant challenges, notably the excessive cost of novel pharmaceuticals.
- Addressing these systemic issues requires substantial reform, with a projected timeline extending to 2028.
Purpose of the Study:
- To propose a radical solution for reforming medical care, focusing on cost containment and value.
- To introduce a heuristic model incorporating value as a primary criterion for reform.
Main Methods:
- Development of a heuristic model to guide reform implementation.
- Establishment of a special committee, appointed by the president, to oversee reforms.
Main Results:
- The proposed model aims to integrate 'value' as a central metric in assessing medical interventions and drug pricing.
- The committee's presidential appointment signifies a high-level commitment to enacting these changes.
Conclusions:
- Implementing a value-based heuristic model and a dedicated presidential committee can address critical issues like drug costs.
- The proposed reforms offer a structured approach to improving medical care efficiency and affordability by 2028.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.6K
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
9.8K
Related Concept Videos
01:16Bioequivalence: Overview
1.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.2K
01:23Methods of Documentation V: CBE
983
Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
983
01:17Drug Nomenclature
2.3K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
2.3K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
252
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
252
01:02Prescription, Nonprescription and Orphan Drugs
849
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
849
01:25Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K